TR200101654T2 - Vitronektin reseptr antagonistleri - Google Patents
Vitronektin reseptr antagonistleriInfo
- Publication number
- TR200101654T2 TR200101654T2 TR2001/01654T TR200101654T TR200101654T2 TR 200101654 T2 TR200101654 T2 TR 200101654T2 TR 2001/01654 T TR2001/01654 T TR 2001/01654T TR 200101654 T TR200101654 T TR 200101654T TR 200101654 T2 TR200101654 T2 TR 200101654T2
- Authority
- TR
- Turkey
- Prior art keywords
- vitronectin receptor
- receptor antagonists
- vitronectin
- osteoporosis
- describes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Bir vitronektin reseptör antagonisti olup osteoporozun tedavisinde faydal olan bir formül (I) bileçiGi veya bunun farmasötik olarak kabul edilebilir bir tuzu anlat lmaktad r.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11090398P | 1998-12-04 | 1998-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200101654T2 true TR200101654T2 (tr) | 2002-03-21 |
Family
ID=22335565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/01654T TR200101654T2 (tr) | 1998-12-04 | 1999-12-03 | Vitronektin reseptr antagonistleri |
Country Status (39)
Country | Link |
---|---|
US (1) | US6495560B1 (tr) |
EP (1) | EP1146874B1 (tr) |
JP (1) | JP4481504B2 (tr) |
KR (1) | KR100620485B1 (tr) |
CN (1) | CN1147300C (tr) |
AP (1) | AP1534A (tr) |
AR (1) | AR035006A1 (tr) |
AT (1) | ATE277043T1 (tr) |
AU (1) | AU754408B2 (tr) |
BG (1) | BG65118B1 (tr) |
BR (1) | BR9915879A (tr) |
CA (1) | CA2353415A1 (tr) |
CO (1) | CO5150166A1 (tr) |
CZ (1) | CZ20011963A3 (tr) |
DE (1) | DE69920518T2 (tr) |
DK (1) | DK1146874T3 (tr) |
DZ (1) | DZ2954A1 (tr) |
EA (1) | EA003254B1 (tr) |
EG (1) | EG24025A (tr) |
ES (1) | ES2229798T3 (tr) |
HK (1) | HK1042037B (tr) |
HU (1) | HUP0104804A3 (tr) |
ID (1) | ID28811A (tr) |
IL (2) | IL143390A0 (tr) |
MA (1) | MA25265A1 (tr) |
NO (1) | NO318895B1 (tr) |
NZ (1) | NZ511876A (tr) |
OA (1) | OA11724A (tr) |
PE (1) | PE20001563A1 (tr) |
PL (1) | PL195973B1 (tr) |
PT (1) | PT1146874E (tr) |
SI (1) | SI1146874T1 (tr) |
SK (1) | SK7452001A3 (tr) |
TR (1) | TR200101654T2 (tr) |
TW (1) | TW482673B (tr) |
UA (1) | UA71586C2 (tr) |
UY (1) | UY25824A1 (tr) |
WO (1) | WO2000033838A1 (tr) |
ZA (1) | ZA200104398B (tr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6900232B2 (en) | 2000-06-15 | 2005-05-31 | Pharmacia Corporation | Cycloalkyl alkanoic acids as integrin receptor antagonists |
EP1331937B1 (en) * | 2000-10-24 | 2006-03-15 | Merck & Co., Inc. | Dibenzoxazepine alpha v integrin receptor antagonist |
CA2436130A1 (en) | 2001-01-29 | 2002-08-08 | 3-Dimensional Pharmaceuticals, Inc. | Substituted indoles and their use as integrin antagonists |
US6872730B2 (en) | 2001-04-27 | 2005-03-29 | 3-Dimensional Pharmaceuticals, Inc. | Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
US20040224986A1 (en) | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
WO2004058760A1 (en) | 2002-12-20 | 2004-07-15 | Pharmacia Corporation | Thiazole compounds as integrin receptor antagonists derivatives |
GB0319069D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Therapeutically useful compounds |
WO2006069079A2 (en) * | 2004-12-21 | 2006-06-29 | Smithkline Beecham Corporation | Methods and formulations |
EP2593452B1 (en) | 2010-07-14 | 2017-01-18 | Novartis AG | Ip receptor agonist heterocyclic compounds |
CN104053659B (zh) | 2012-01-13 | 2016-11-09 | 诺华股份有限公司 | 用于治疗肺动脉高压(pah)及相关病症的作为ip 受体激动剂的稠合的吡咯类 |
EP2956455B1 (en) | 2013-02-13 | 2017-05-17 | Novartis AG | Ip receptor agonist heterocyclic compounds |
PT3050878T (pt) | 2013-09-24 | 2021-12-02 | Fujifilm Corp | Novo composto contendo azoto ou seu sal, ou seu complexo de metal |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687154B1 (fr) * | 1992-02-07 | 1995-05-12 | Rhone Poulenc Rorer Sa | Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent. |
PT910563E (pt) * | 1995-06-29 | 2003-09-30 | Smithkline Beecham Corp | Antagonistas de receptores de integrina |
AU4109297A (en) * | 1996-09-27 | 1998-04-17 | Merkler, H. | Tank for liquids, particularly for chemically aggressive liquids |
WO1998015278A1 (en) | 1996-10-07 | 1998-04-16 | Smithkline Beecham Corporation | Method for stimulating bone formation |
UY24949A1 (es) | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
-
1999
- 1999-03-12 UA UA2001063754A patent/UA71586C2/uk unknown
- 1999-11-29 UY UY25824A patent/UY25824A1/es unknown
- 1999-11-29 TW TW088120752A patent/TW482673B/zh not_active IP Right Cessation
- 1999-11-30 PE PE1999001197A patent/PE20001563A1/es not_active Application Discontinuation
- 1999-11-30 CO CO99075061A patent/CO5150166A1/es unknown
- 1999-12-01 DZ DZ990254A patent/DZ2954A1/xx active
- 1999-12-02 EG EG154299A patent/EG24025A/xx active
- 1999-12-02 AR ARP990106128A patent/AR035006A1/es unknown
- 1999-12-03 JP JP2000586330A patent/JP4481504B2/ja not_active Expired - Fee Related
- 1999-12-03 SI SI9930700T patent/SI1146874T1/xx unknown
- 1999-12-03 EA EA200100618A patent/EA003254B1/ru not_active IP Right Cessation
- 1999-12-03 CA CA002353415A patent/CA2353415A1/en not_active Abandoned
- 1999-12-03 DE DE69920518T patent/DE69920518T2/de not_active Expired - Lifetime
- 1999-12-03 ID IDW00200101183A patent/ID28811A/id unknown
- 1999-12-03 CZ CZ20011963A patent/CZ20011963A3/cs unknown
- 1999-12-03 AU AU17502/00A patent/AU754408B2/en not_active Ceased
- 1999-12-03 ES ES99960647T patent/ES2229798T3/es not_active Expired - Lifetime
- 1999-12-03 KR KR1020017006937A patent/KR100620485B1/ko not_active IP Right Cessation
- 1999-12-03 SK SK745-2001A patent/SK7452001A3/sk unknown
- 1999-12-03 CN CNB998159735A patent/CN1147300C/zh not_active Expired - Fee Related
- 1999-12-03 EP EP99960647A patent/EP1146874B1/en not_active Expired - Lifetime
- 1999-12-03 DK DK99960647T patent/DK1146874T3/da active
- 1999-12-03 AP APAP/P/2001/002156A patent/AP1534A/en active
- 1999-12-03 OA OA1200100139A patent/OA11724A/en unknown
- 1999-12-03 HU HU0104804A patent/HUP0104804A3/hu unknown
- 1999-12-03 AT AT99960647T patent/ATE277043T1/de not_active IP Right Cessation
- 1999-12-03 PT PT99960647T patent/PT1146874E/pt unknown
- 1999-12-03 TR TR2001/01654T patent/TR200101654T2/tr unknown
- 1999-12-03 BR BR9915879-5A patent/BR9915879A/pt not_active Application Discontinuation
- 1999-12-03 NZ NZ511876A patent/NZ511876A/xx unknown
- 1999-12-03 PL PL99348702A patent/PL195973B1/pl not_active IP Right Cessation
- 1999-12-03 US US09/857,316 patent/US6495560B1/en not_active Expired - Lifetime
- 1999-12-03 IL IL14339099A patent/IL143390A0/xx active IP Right Grant
- 1999-12-03 WO PCT/US1999/028662 patent/WO2000033838A1/en active IP Right Grant
-
2001
- 2001-05-24 IL IL143390A patent/IL143390A/en not_active IP Right Cessation
- 2001-05-29 ZA ZA200104398A patent/ZA200104398B/en unknown
- 2001-06-01 NO NO20012732A patent/NO318895B1/no not_active IP Right Cessation
- 2001-06-01 MA MA26218A patent/MA25265A1/fr unknown
- 2001-06-26 BG BG105651A patent/BG65118B1/bg unknown
-
2002
- 2002-02-27 HK HK02101522.3A patent/HK1042037B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE372768T1 (de) | N-(2-arylethyl) benzylamine als 5-ht6 rezeptor- antagoniste | |
IS6362A (is) | Úrea (eða þvagefnis) efnasambönd sem hafa múskarín viðtaka mótlyfs virkni | |
TR200101155T2 (tr) | 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III | |
TR200000786T2 (tr) | Vitronektin reseptör antagonisti | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
TR199801255T2 (tr) | Vitronektin reseptör antagonistleri. | |
TR199801253T2 (tr) | Vitronektin reseptörü antagonistleri. | |
IL155702A0 (en) | Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5-ht2 receptor | |
ATE356119T1 (de) | Pyrimidinone als melanin concentrating hormone receptor 1 | |
TR200101397T2 (tr) | Piperidin CCR-3 reseptörü antagonistleri | |
BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
BR0014651A (pt) | Inibidores de adesão de célula mediada por "alfa" l beta2 | |
ATE225349T1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
TR200000792T2 (tr) | Vitronektin reseptör antagonistleri. | |
TR200101654T2 (tr) | Vitronektin reseptr antagonistleri | |
TR200403436T2 (tr) | Kristalin 1-metilkarbapenem türevleri. | |
TR200102178T2 (tr) | CRF reseptör antagonistleri ve bunlarla ilgili yöntemler. | |
NO975975L (no) | Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav | |
TR200000721T2 (tr) | Vitronektin reseptör antagonistleri. | |
RS20060072A (en) | Aminoquinoline derivatives and their use as adenosine a3 ligands | |
TR200001452T2 (tr) | Bifenilamidin türevleri. | |
MXPA05005198A (es) | Derivados de imidazoquinolina, como ligandos del receptor a3 de adenosina. | |
DE50008020D1 (de) | Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten | |
NO20035148D0 (no) | Tri- og tetra-aza-acenaftylenderivater som CRF- reseptorantagonister | |
TR200200614T2 (tr) | Vitronektin reseptörü antagonistleri |